Ho Tony W
Insider CIK 1713637 · CRSP See Remarks · ITOS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-12-06 | 2021-12-07 | 12,607 | $69.17 | $872.0K | 52,364 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2021-12-03 | 2021-12-07 | 26,667 | — | $0 | 13,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-12-03 | 2021-12-07 | 26,667 | — | $0 | 64,971 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-10-15 | 2021-10-18 | 13,800 | — | $0 | 13,800 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 4,560 | — | $0 | 4,560 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-04-29 | 2021-05-03 | 33,217 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 23,334 | — | $0 | 23,334 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-03-11 | 2021-03-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-03-10 | 2021-03-12 | 2,141 | $124.15 | $265.8K | 38,304 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-10 | 2021-03-12 | 4,583 | — | $0 | 40,445 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2021-03-05 | 2021-03-09 | 1,585 | $114.65 | $181.7K | 35,862 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2021-03-05 | 2021-03-09 | 3,333 | — | $0 | 37,447 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-12-21 | 2020-12-22 | 23,551 | — | $0 | 236,449 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 500 | $152.41 | $76.2K | 51,715 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-12-21 | 2020-12-22 | 23,551 | $16.90 | $398.0K | 57,515 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 1,700 | $148.11 | $251.8K | 55,815 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 900 | $149.18 | $134.3K | 54,915 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 1,600 | $150.16 | $240.3K | 53,315 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 1,100 | $151.58 | $166.7K | 52,215 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 1,400 | $147.05 | $205.9K | 50,315 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 8,400 | $148.38 | $1.25M | 41,915 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 5,000 | $149.73 | $748.6K | 36,915 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-12-21 | 2020-12-22 | 2,951 | $150.61 | $444.5K | 33,964 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-10-05 | 2020-10-06 | 16,666 | — | $0 | 16,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-23 | 2020-06-24 | 6,929 | $75.20 | $521.1K | 33,747 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-22 | 2020-06-24 | 229 | $70.14 | $16.1K | 40,676 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-26 | 2020-05-27 | 6,100 | $70.14 | $427.9K | 40,905 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-22 | 2020-05-27 | 600 | $70.05 | $42.0K | 47,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 13,750 | — | $0 | 13,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-03-10 | 2020-03-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2020-03-06 | 2020-03-09 | 1,563 | $52.64 | $82.3K | 47,605 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-03-05 | 2020-03-09 | 3,333 | — | $0 | 49,168 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-12-03 | 2019-12-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2019-08-02 | 2019-08-05 | 14,534 | $52.56 | $763.9K | 45,835 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-08-01 | 2019-08-05 | 37,500 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-08-01 | 2019-08-05 | 37,500 | — | $0 | 60,369 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-03-05 | 2019-03-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award | 2019-03-05 | 2019-03-07 | 10,000 | $40.87 | $408.7K | 32,869 | SEC↗ |
| CRSP CRISPR Therapeutics AG | F Tax w/h | 2018-08-02 | 2018-08-03 | 14,631 | $48.43 | $708.6K | 22,869 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2018-08-01 | 2018-08-03 | 37,500 | — | $0 | 37,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2018-08-01 | 2018-08-03 | 37,500 | — | $0 | 37,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-06-15 | 2018-06-15 | 43,000 | — | $0 | 43,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-03-07 | 2018-03-09 | 53,000 | — | $0 | 53,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-08-01 | 2017-08-02 | 260,000 | — | $0 | 260,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-08-01 | 2017-08-02 | 75,000 | — | $0 | 75,000 | SEC↗ |